DarioHealth Corp. (DRIO) › Cash & EquivalentsDarioHealth Corp. (DRIO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $908.8K2012: $1.23M2013: $2.26M2014: $1.45M2015: $2.67M2016: $1.09M2017: $3.72M2018: $11.00M2019: $20.39M2020: $28.59M2021: $35.81M2022: $49.36M2023: $36.80M2024: $27.76M2025: $21.80M$21.80M2011Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$21.80M-21.5%2024$27.76M-24.5%2023$36.80M-25.4%2022$49.36M+37.8%2021$35.81M+25.2%2020$28.59M+40.2%2019$20.39M+85.5%2018$11.00M+195.8%2017$3.72M+240.2%2016$1.09M-59.1%2015$2.67M+83.8%2014$1.45M-35.8%2013$2.26M+84.0%2012$1.23M+35.3%2011$908.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share